As of 2025-10-20, the Relative Valuation of Cardiol Therapeutics Inc (CRDL.TO) is (3.91) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.46 CAD, the upside of Cardiol Therapeutics Inc based on Relative Valuation is -367.8%.
The range of the Relative Valuation is (3.22) - (4.56) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 10.4x | 8.7x |
| Forward P/E multiples | 7.4x - 11.0x | 9.2x |
| Fair Price | (3.22) - (4.56) | (3.91) |
| Upside | -320.3% - -412.4% | -367.8% |
| Date | P/E |
| 2025-10-16 | -3.34 |
| 2025-10-15 | -3.50 |
| 2025-10-14 | -3.34 |
| 2025-10-10 | -3.34 |
| 2025-10-09 | -3.52 |
| 2025-10-08 | -3.43 |
| 2025-10-07 | -3.43 |
| 2025-10-06 | -3.43 |
| 2025-10-03 | -3.41 |
| 2025-10-02 | -3.32 |
| 2025-10-01 | -3.43 |
| 2025-09-30 | -3.46 |
| 2025-09-29 | -3.62 |
| 2025-09-26 | -3.46 |
| 2025-09-25 | -3.50 |
| 2025-09-24 | -3.46 |
| 2025-09-23 | -3.52 |
| 2025-09-22 | -3.52 |
| 2025-09-19 | -3.55 |
| 2025-09-18 | -3.46 |
| 2025-09-17 | -3.43 |
| 2025-09-16 | -3.36 |
| 2025-09-15 | -3.41 |
| 2025-09-12 | -3.46 |
| 2025-09-11 | -3.39 |
| 2025-09-10 | -3.43 |
| 2025-09-09 | -3.32 |
| 2025-09-08 | -3.36 |
| 2025-09-05 | -3.52 |
| 2025-09-04 | -3.50 |
| 2025-09-03 | -3.46 |
| 2025-09-02 | -3.48 |
| 2025-08-29 | -3.41 |
| 2025-08-28 | -3.46 |
| 2025-08-27 | -3.57 |
| 2025-08-26 | -3.62 |
| 2025-08-25 | -3.66 |
| 2025-08-22 | -3.71 |
| 2025-08-21 | -3.71 |
| 2025-08-20 | -3.66 |
| 2025-08-19 | -3.59 |
| 2025-08-18 | -3.87 |
| 2025-08-15 | -4.19 |
| 2025-08-14 | -4.23 |
| 2025-08-13 | -3.50 |
| 2025-08-12 | -3.52 |
| 2025-08-11 | -3.20 |
| 2025-08-08 | -3.20 |
| 2025-08-07 | -3.39 |
| 2025-08-06 | -3.39 |